Biotech News

Fresenius Medical Care marks World Kidney Day and National Kidney Month

Fresenius Medical Care Ventures (FMS)Fresenius Medical Care Ventures2026-03-09 23:00 ESTCompany update

03/10/2026 | Short News

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is joining the global community to mark World Kidney Day on March 12 and National Kidney Month in the U.S. throughout March. These annual observances highlight the importance of kidney health, early detection, and education to help reduce the risk of chronic kidney disease (CKD).

Often referred to as a “silent condition,” kidney disease can progress with few or no symptoms in its early stages. Millions of people worldwide are living with CKD, many without knowing it. As a trusted leader in kidney care, Fresenius Medical Care supports people affected by kidney disease every day through patient‑centered care, innovation, and education.

To celebrate National Kidney Month in the U.S., Fresenius Kidney Care is unveiling a reimagined kidney care education program. This clinically approved curriculum is designed to support people with kidney disease, and their loved ones, at every stage of the journey.

The program features dynamic, on-demand video modules that allow participants to tailor their learning experience. Individuals can explore topics most relevant to their needs, whether they are newly diagnosed, working to slow progression, or exploring treatment options. Each module delivers practical, real-world guidance in a supportive and empowering way.

Every kidney journey is unique, and education should be, too. Which is why the experience will be available in both self-paced and small group, facilitator-led formats, providing flexibility to meet individual preferences.

Throughout March, Fresenius Medical Care will continue to spotlight kidney health education, awareness, and resources for patients, caregivers, employees, and communities around the world.

Learn more and watch our clinicians discuss what you should know about kidney disease here.

Back

To top:

Open original release

Related news

FMSFresenius Medical Care Ventures2026-07-20 07:00 EST

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

FMSFresenius Medical Care Ventures2026-06-10 07:00 EST

Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model

FMSFresenius Medical Care Ventures2026-06-03 07:00 EST

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

FMSFresenius Medical Care Ventures2026-05-28 07:00 EST

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

FMSFresenius Medical Care Ventures2026-05-27 13:00 EST

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

FMSFresenius Medical Care Ventures2026-05-25 22:00 EST

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

FMSFresenius Medical Care Ventures2026-05-20 22:00 EST

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

FMSFresenius Medical Care Ventures2026-05-19 22:00 EST

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

FMSFresenius Medical Care Ventures2026-05-05 05:00 EST

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

FMSFresenius Medical Care Ventures2026-03-11 23:00 EST

Fresenius Medical Care publishes its Annual Report 2025: The power of care

Fresenius Medical Care Ventures

Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.

Recent company news

Stock data

Close
24.07 USD
Market cap
11.04B USD
Exchange
NYSE
Sector
Biotechnology
Location
United States